DyoDelta Biosciences Ltd., is a London based company specialising in deals in the Pharma / Biotech sector.
We provide best-practice in corporate transactions through our management and associates. DyoDelta Biosciences is an elite group of senior executives with actual deal-making experience in the pharma and biotech industry at the corporate HQ level. We work closely with our clients/partners to put together collaborations in the life sciences.

DyoDelta Biosciences' team averages more than 20 years experience per person and more than 150 years of cumulative experience. DyoDelta Biosciences has thousands of contacts at the senior corporate level worldwide and across the life sciences industry. The team's executives have put together multiple types of deals, including R&D collaborations, strategic alliances, product licensing, acquisitions, disposals, financings and local geography partnering, with NPVs adding to many billions of dollars.

DyoDelta Biosciences covers Europe, the US and Japan, in guiding and supporting pharma and biotech companies, investors, institutions and organisations in corporate transactions, evaluation and due diligence, including:

Strategic Planning
Preparation of materials for partnering transactions
Identification of potential partners
Identification of new compounds and technologies
Initiation of contacts and discussions
Developing market projections
Commercial Analysis and Financial Valuations
Technical Due Diligence support
Deal structuring
Development of commercial, intellectual property and other terms
Generating optimal financial terms
Negotiations

CONTACT

DyoDelta Biosciences Ltd
Berkeley Square House
Berkeley Square
London W1J 6BD
U.K.

Contact person: Mr. D. Dimitriou, CEO

Phone: +44 20 7396 5572
Fax: +44 20 7396 5599

Visit us at www.dyodelta.com